Federal update: DOJ partially rescheduled medical cannabis to Schedule III (April 28, 2026 final order). State-licensed medical operators may apply for expedited DEA registration through June 27, 2026; DEA hearing on full rescheduling set for June 29, 2026.

HB 5259 (2026) — The Home-Grow Bill That Did Not Advance

House Bill 5259 would have authorized West Virginia registered medical cannabis patients to cultivate up to 10 plants (5 mature) for personal use — ending the Mountain State’s blanket cultivation prohibition that exposes even patients to felony charges of 1–5 years and up to $15,000 fine under W. Va. Code § 60A-4-401(a). The bill did not advance during the 2026 session; without it, even one plant remains a felony for any West Virginian, registered or not. Home-grow expansion is one of the longest-standing reform asks from West Virginia NORML, the Compassion Coalition, and Del. Mike Pushkin (HB 3230 in earlier sessions). With HB 5260 (edibles) also dead, the 2026 session passed 306 bills and zero substantive cannabis-reform bills.

Last verified: May 2026

The Status Quo — Felony From One Plant

West Virginia is one of a small number of medical-cannabis states whose statute treats cultivation of even a single plant as a felony, and the only one of the Mountain State’s legalized neighbors with that posture (Pennsylvania medical also bans patient cultivation; Maryland adult-use allows 2 plants per adult / 4 per household; Ohio adult-use allows 6 plants per adult / 12 per household). Cultivation falls under "manufacture" in W. Va. Code § 60A-4-401(a):

  • 1–5 years prison
  • Up to $15,000 fine
  • Even a single mature plant produces felony exposure
  • Registered medical cardholders enjoy NO cultivation defense — SB 386 did not authorize home grow

West Virginia courts have consistently treated even a single mature plant as falling within the felony manufacturing range. See WV cultivation-felony page.

What HB 5259 Would Have Done

House Bill 5259 of the 2026 West Virginia regular session would have amended W. Va. Code ch. 16A (the Medical Cannabis Act) to authorize registered medical cannabis patients to grow:

  • Up to 10 plants total per registered patient
  • Up to 5 mature (flowering) plants at any one time
  • For personal use only — no sale, no distribution, no transfer
  • Cultivation in a secure, enclosed area not visible from public right-of-way
  • Tied to the patient’s registered residence address on the OMC card
  • No corresponding amendment to W. Va. Code § 60A-4-401(a) — non-patients still face felony for any cultivation

The 10-plant / 5-mature framework mirrors the patient cultivation provisions in Maine, Massachusetts, and (in part) Connecticut medical programs — among the more permissive patient-cultivation regimes nationally. Reform advocates favored this design over a tighter 6-plant / 3-mature framework because of the WV-specific issue of rural distance from dispensaries (McDowell County, Wyoming County, Tucker County, Pocahontas County have minimal in-county dispensary footprints).

The 2026 Session Outcome

HB 5259 did not advance in the 2026 session. The bill did not receive a House Health Committee hearing in time to clear chamber-of-origin deadlines. Speaker Hanshaw (R-Clay) did not bring it to the floor. Companion home-grow legislation introduced by Del. Mike Pushkin (D-Kanawha) in earlier sessions (notably HB 3230) had similarly stalled. The 2026 cycle was the closest home-grow legislation has come to a Floor consideration; it still did not happen. The reasons cited by reform observers:

  • Edibles were the prioritized reform; HB 5260 (edibles) had stronger bipartisan-Republican support and absorbed the political oxygen
  • Diversion concerns (cited by law enforcement) about home-grown product entering the unregulated market
  • Coalfield-Republican opposition consistent with Senate President Smith’s posture
  • OMC operational concerns about METRC tracking of patient home-grown product
See HB 5260 page.

The Patient-Hardship Use Case

Home grow is the lowest-cost long-term cannabis access path for chronic-pain patients. A registered WV patient with severe chronic pain or one of the other 14 qualifying conditions under W. Va. Code § 16A-2-1 currently has these options:

  • Pay $50/year OMC registration plus $99–$249 telemedicine certification
  • Pay dispensary retail prices (typically $40–$60 per 1/8 oz vaporizable flower or $60–$80 per gram concentrate)
  • Travel to nearest in-county or in-region dispensary; for rural southern coalfield counties (McDowell, Wyoming, Mingo) drive distances frequently exceed 60 miles round-trip
  • Subject to the 30-day supply cap enforced by METRC

For a chronic-pain patient on fixed income (Social Security disability, SSI), the annual dispensary cost can run $2,000–$5,000 even with the OMC’s 200%-of-federal-poverty hardship waiver on the registration fee itself. Home cultivation would dramatically lower the long-term cost. See qualifying-conditions page.

Why Patient-Cultivation Reform Is Hard in West Virginia

The political opposition to HB 5259 reflects three structural concerns:

  • Diversion to the gray market: opponents argue patient home-grown product flows into the unregulated market, undermining licensed dispensary revenue and hindering METRC seed-to-sale tracking
  • Federal-grant exposure: WV receives federal law-enforcement grants tied to drug enforcement; home-cultivation expansion can be framed as in tension with grant conditions
  • Industry preference for dispensary channel: licensed dispensaries (~65 statewide) prefer that patient access remain through their channel, not home cultivation; the WV Cannabis Trade Association has not been a vocal home-grow advocate

Notably, no major West Virginia operator (Trulieve, Verano, Holistic, Curaleaf, Cannabist, Harvest Care) has publicly supported HB 5259 — their economic interest aligns with maintaining dispensary monopoly on supply. See dispensary overview.

Pushkin’s Long-Standing Push

Del. Mike Pushkin (D-Kanawha — the Charleston-area district encompassing the State Capitol) has been the most consistent home-grow advocate in the West Virginia House of Delegates since SB 386 enactment in 2017. His earlier vehicle HB 3230 (home cultivation, 5 plants) and a series of variants in 2018, 2019, 2021, 2023, and 2025 sessions all met the same outcome — no floor consideration. Pushkin’s framing emphasizes patient cost, rural access, and racial-disparity remediation (Black West Virginians arrested for cannabis at 7.3 times the rate of white West Virginians per ACLU analysis). See WV reform coalition page.

The 2027 Outlook

Home-grow legislation faces a steeper Senate path than edibles. The most realistic 2027 vehicle is reissue of HB 5259 with possibly a tighter 6-plant / 3-mature framework to address Senate concerns; clearing the House is plausible, clearing the Smith-led Senate is not. Until a Senate composition change in 2028 (next regular Senate cycle) or a leadership change, home grow remains the harder reform. With HB 5260 (edibles) the more probable 2027 priority, advocates expect home-grow legislation to return but not necessarily to advance.